v3.24.1.u1
Collaborations (Tables)
 3 Months Ended
Mar. 31, 2024
Janssen Biotech Inc.  
Collaborative and license agreements  
Schedule of profit and cost sharing relationship
The following table shows the profit and cost sharing relationship between Janssen and AbbVie:
Three months ended
March 31,
(in millions)20242023
United States - Janssen's share of profits (included in cost of products sold)$283 $297 
International - AbbVie's share of profits (included in net revenues)228 240 
Global - AbbVie's share of other costs (included in respective line items)42 55 
Genentech, Inc.  
Collaborative and license agreements  
Schedule of profit and cost sharing relationship The following table shows the profit and cost sharing relationship between Genentech and AbbVie:
Three months ended
March 31,
(in millions)20242023
Genentech's share of profits, including royalties (included in cost of products sold)$227 $202 
AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&A)9 11 
AbbVie's share of development costs (included in R&D)19 28